Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02314143
Brief Title: Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib

First Submitted : September 25, 2013
First Submitted that Met QC Criteria : December 8, 2014
First Posted : December 11, 2014 (Estimate)

Results First Submitted : January 11, 2018
Results First Submitted that Met QC Criteria : October 10, 2018
Results First Posted : February 18, 2019

Last Update Submitted that Met QC Criteria : October 10, 2018
Last Update Posted : February 18, 2019